CDEX (Old)

[doyourdd]

What's this: PALOMAR MEDICAL TECH Form 10K Filing Date 4-14-1998
Excerpts…

Wellman Laboratories ("Wellman Labs"), the world's largest biomedical laser research facility and part of the MGH Laser Center located in Boston, Massachusetts, was created to oversee and speed the flow of biomedical laser research from the laboratory to patient care. Funded in part by a grant from the Department of Energy, the MGH Laser Center brings together two strengths of MGH:
its clinical departments and the Wellman Labs. The MGH Laser Center works together with industry, academia and the Department of Energy Laboratories to access information and technology across a broad spectrum of laser and medical capabilities. The principals at Wellman Labs study the fundamental photophysical and photochemical properties and processes of biomolecules excited by ultraviolet, visible and near infrared radiation. Engineers, laser physicists and physicians familiar with all aspects of biomolecules, cells and tissue in vitro staff the labs. The scientists work side by side with the clinicians to understand the basic principles involved in the complex interactions of light and tissue. In 1994, the Company began a number of studies for the treatment of certain dermatological conditions using its diode laser at Wellman Labs. In 1995, those studies were expanded to include the Company's ruby lasers for cosmetic procedures. In 1997, those studies were again expanded to include the Company's diode lasers for cosmetic purposes. Wellman Labs and the Company are currently evaluating the data associated with these treatments. The Company works closely with Dr. R. Rox Anderson, the Research Director of the MGH Laser Center and Associate Professor of Dermatology at Harvard Medical School, who is a recognized expert in laser tissue interaction and the inventor of a number of laser procedures in use today. Dr. Anderson has authored over 60 papers in peer-reviewed publications relating to the use of lasers in dermatology, is the recipient of numerous awards in the field of laser medicine and serves as a member of the Blue Ribbon Government Liaison Committee of the American Society for Laser Medicine and Surgery. Dr. Anderson holds ten U.S. patents and has pending applications for an additional eleven. The Company feels that these types of relationships are critical in developing effective products for widespread use in the market on a timely basis, and that this method of conducting research and development provides a higher level of technical and clinical expertise than it could provide on its own and in a more cost-efficient manner.

PMP's Vice President of Research and Development, Gregory Altshuler, is the former Director of the Laser Center of the St. Petersburg (Russia) Institute of Fine Mechanics and Optics (the "St. Petersburg Laser Center)" and the Company continues to work closely with the St. Petersburg Laser Center, contracting out research and development tasks to them on a project basis. Palomar owns all inventions, developments and patents which result from the work performed at the St. Petersburg Laser Institute and funded by Palomar. In 1997, the Company spent approximately $100,000 on research and development conducted at the St. Petersburg Laser Institute. Dr. Altshuler holds approximately 50 patents in Russia in the field of lasers and the application of lasers in medicine, and has authored approximately 130 papers relating to laser physics, engineering and medicine.

While MGH focuses on the biological aspects of laser hair removal, Dr. Altshuler's in-house research and development team focuses on the physical aspects. Approximately 40 employees of the Company and its subsidiaries were engaged full time in research and development activities at December 31, 1997.

Pursuant to the Sales Agency, Development and License Agreement that the Company entered into with Coherent in November 1997, the Company has committed to spend the following amounts on research and development over the next three years: at least $5,000,000 in 1998, at least 10% of its 1998 gross revenues (minus commissions to Coherent) from cosmetic laser products ("Product Revenues") in 1999, and at least 10% of its 1999 Product Revenues in 2000.

= = = = = = =

BioProgress (BPRG) is interesting to me with Wellman Labs appearing in their SEC filings

BioProgress (BPRG) is interesting to me with Brunel University appearing

http://itprofessionalsurvival.com/content/view/1368/2/

Brunel University In-Cylinder Fuel and Species Measurements by Planar Laser Induced Fluorescence (PLIF)

http://dea.brunel.ac.uk/research/cerg/recent/plif.html

BioProgress (BPRG) is interesting to me, and it seems to be interesting to Raging Bull posters:
Lmorovan
stock_distributor
coquille
himanez
diddy
mike2999

Consider stock_distributor for example…

http://ragingbull.lycos.com/mboard/boards.cgi?board=BPRG&read=7344
Bioprogress Plc (BB: BPRG)
BPRG Quote | BPRG Msg Board | BPRG LiveCharts | BPRG Chart | BPRG News | BPRG Company Info | BPRG I-Watch | BPRG Insider | BPRG Analyst Recs | BPRG Top Holders


« BPRG Message list | Reply to msg. | Post new msg. « Older | Newer »
By: stock_distributor
29 Jan 2003, 03:01 PM EST
Msg. 7344 of 9882
Jump to msg. #
Does anyone know when we might expect to see the registration of the private unit holders shares???

Every month increases their holdings by 1/10th of the original placement. This dilution of the common holder should be halted via registration of their shares at the earliest practicable date before the 90% cap is hit.

Thank you.



t's this: